Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Sargramostim Pregnancy and Breastfeeding Warnings

Sargramostim is also known as: Leukine

Medically reviewed on Sep 17, 2018

Sargramostim Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: C

Comments: Female patients of childbearing potential should be apprised of the potential harm to the fetus.

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Sargramostim Breastfeeding Warnings

This drug should be used only if clearly needed.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Leukine (sargramostim)." Immunex Corporation, Seattle, WA.

References for breastfeeding information

  1. "Product Information. Leukine (sargramostim)." Immunex Corporation, Seattle, WA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide